as the pace of innovation continues, it is growing more difficult to see the value of technology. often meaningful information is inaccessible at the time it would be most beneficial. weave threads together data, software and communication platforms to build stronger relationships at the point of contact by making valuable information instantly available in simple and intuitive formats. this delivers improved productivity, better collaboration and greater insights making it easier to meet the needs of patients and to build better business and clinical outcomes.
Company profile
Ticker
WEAV
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Microsoft • Oracle • Mobileye Global Inc - Ordinary Shares • Activision Blizzard • Gen Digital • Vmware • Adobe • Salesforce • BlackBerry • Dayforce ...
SEC CIK
Corporate docs
IRS number
263302902
WEAV stock data
Latest filings (excl ownership)
ARS
2024 FY
Annual report to shareholders
9 Apr 24
DEFA14A
Additional proxy soliciting materials
9 Apr 24
DEF 14A
Definitive proxy
9 Apr 24
8-K
Departure of Directors or Certain Officers
26 Mar 24
10-K
2023 FY
Annual report
13 Mar 24
8-K
Weave Announces Fourth Quarter and Full Year 2023 Financial Results
21 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Weave Announces Third Quarter 2023 Financial Results
1 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
Weave Announces Second Quarter 2023 Financial Results
2 Aug 23
Transcripts
WEAV
Earnings call transcript
2023 Q4
21 Feb 24
WEAV
Earnings call transcript
2023 Q3
1 Nov 23
WEAV
Earnings call transcript
2023 Q2
2 Aug 23
WEAV
Earnings call transcript
2023 Q1
3 May 23
WEAV
Earnings call transcript
2022 Q4
22 Feb 23
WEAV
Earnings call transcript
2022 Q3
5 Nov 22
WEAV
Earnings call transcript
2022 Q2
7 Aug 22
WEAV
Earnings call transcript
2022 Q1
7 May 22
WEAV
Earnings call transcript
2021 Q4
3 Mar 22
WEAV
Earnings call transcript
2021 Q3
7 Dec 21
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 63.29 mm | 63.29 mm | 63.29 mm | 63.29 mm | 63.29 mm | 63.29 mm |
Cash burn (monthly) | (no burn) | 4.59 mm | 2.67 mm | 3.01 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | 31.46 mm | 18.33 mm | 20.63 mm | n/a | n/a |
Cash remaining | n/a | 31.83 mm | 44.96 mm | 42.66 mm | n/a | n/a |
Runway (months of cash) | n/a | 6.9 | 16.8 | 14.2 | n/a | n/a |
Institutional ownership, Q3 2023
98.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 106 |
Opened positions | 14 |
Closed positions | 15 |
Increased positions | 46 |
Reduced positions | 25 |
13F shares | Current |
---|---|
Total value | 363.74 bn |
Total shares | 70.18 mm |
Total puts | 35.70 k |
Total calls | 34.40 k |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
Catalyst Investors IV | 10.93 mm | $0.00 |
Crosslink Capital | 9.62 mm | $78.40 bn |
Deer IX & Co. | 7.57 mm | $114.86 mm |
Deer Management | 7.14 mm | $58.17 bn |
Pelion | 5.55 mm | $45.19 bn |
Pelion Ventures VI | 4.85 mm | $0.00 |
Vanguard | 2.94 mm | $23.98 bn |
BLK Blackrock | 2.12 mm | $17.26 bn |
MS Morgan Stanley | 2.11 mm | $17.21 bn |
Wasatch Advisors | 1.84 mm | $15.01 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Apr 24 | Alan Taylor | Common Stock | Payment of exercise | Dispose F | No | No | 11.58 | 700 | 8.11 k | 560,726 |
15 Mar 24 | Branden Neish | Common Stock | Grant | Acquire A | No | No | 0 | 140,000 | 0.00 | 611,628 |
15 Mar 24 | Branden Neish | Common Stock | Payment of exercise | Dispose F | No | No | 11.26 | 14,832 | 167.01 k | 471,628 |
15 Mar 24 | Alan Taylor | Common Stock | Grant | Acquire A | No | No | 0 | 115,000 | 0.00 | 561,426 |
15 Mar 24 | Alan Taylor | Common Stock | Payment of exercise | Dispose F | No | No | 11.26 | 33,248 | 374.37 k | 446,426 |
15 Mar 24 | Brett T White | Common Stock | Grant | Acquire A | No | No | 0 | 414,100 | 0.00 | 2,332,651 |
15 Mar 24 | Brett T White | Common Stock | Payment of exercise | Dispose F | No | No | 11.26 | 138,703 | 1.56 mm | 1,918,551 |
News
Weave (WEAV) Improves DrChrono Integration for SMB Healthcare
4 Apr 24
Forecasting The Future: 4 Analyst Projections For Weave Communications
26 Feb 24
Piper Sandler Reiterates Overweight on Weave Communications, Maintains $15 Price Target
22 Feb 24
Weave Communications: Q4 Earnings Insights
21 Feb 24
Weave Communications Q4 2023 Adj EPS $(0.01) Beats $(0.03) Estimate, Sales $45.69M Beat $44.20M Estimate
21 Feb 24
Press releases
Weave Announces Date of First Quarter 2024 Financial Results and Conference Call
17 Apr 24
Weave Now Integrates with Shepherd
15 Apr 24
Weave Named to the 2024 Women Tech Council Shatter List for Third Consecutive Year
10 Apr 24
One-Third of Patients Delay Healthcare Due to Cost, New Weave Survey Reveals
4 Apr 24
Weave Enhances Integration with DrChrono by EverHealth
3 Apr 24